| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/12/2009 | US20090068097 Method for non-invasive detection and treatment of cerebral aneurysms |
| 03/12/2009 | US20090068096 Sequence of stro-1 antibody variable region |
| 03/12/2009 | US20090068095 Carbonic anhydrase ix (g250) anitbodies and methods of use thereof |
| 03/12/2009 | DE102007056231A1 Proteins comprising a Kunitz domain useful as protease inhibitors for therapeutic purposes |
| 03/12/2009 | CA2736661A1 Novel fungal enzymes |
| 03/12/2009 | CA2698636A1 Anti-chikungunya monoclonal antibodies and uses thereof |
| 03/12/2009 | CA2698419A1 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof |
| 03/12/2009 | CA2698287A1 Antibodies and related molecules that bind to 24p4c12 proteins |
| 03/12/2009 | CA2697922A1 Compositions that bind multiple epitopes of igf-1r |
| 03/12/2009 | CA2697612A1 Anti-igf-1r antibodies and uses thereof |
| 03/12/2009 | CA2697482A1 Combination therapy with type i and type ii anti-cd20 antibodies |
| 03/12/2009 | CA2696210A1 Compositions and methods comprising binding proteins for adalimumab |
| 03/12/2009 | CA2695309A1 Methods for recombinant manufacturing of anti-rsv antibodies |
| 03/12/2009 | CA2690974A1 Bone morphogenetic protein (bmp)-binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and use of same |
| 03/11/2009 | EP2034030A2 Novel compositions and methods for cancer |
| 03/11/2009 | EP2034023A1 C-C CKR-5 ,CC-Chemikines receptor, derivatives thereof and their uses |
| 03/11/2009 | EP2034017A1 Gene involved in immortalization of human cancer cell and use thereof |
| 03/11/2009 | EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033971A1 Bone Morphogenetic Protein (BMP) binding domains of proteins of the Repulsive Guidance Molecule (RGM) protein family and functional fragments thereof and their application |
| 03/11/2009 | EP2033970A2 WNT-1 inducible genes |
| 03/11/2009 | EP2033659A2 Inhibitors of complement activation |
| 03/11/2009 | EP2033658A1 Anitbodies to cytokines in the prevention and treatment of inflammatory bowel disease |
| 03/11/2009 | EP2033657A1 Intraoperative trifunctional antibody application for prophylatic intraperitonal tumour cell dissemination |
| 03/11/2009 | EP2032992A1 Method for the selective determination of procalcitonin 1-116 for diagnostic purposes and antibodies and kits for carrying out such a method |
| 03/11/2009 | EP2032699A2 Inhibitors of hcap18/ll-37 for use in the treatment of breast cancer |
| 03/11/2009 | EP2032606A2 Antibodies and immunoconjugates and uses therefor |
| 03/11/2009 | EP2032605A2 HIGH AFFINITY HUMAN AND HUMANIZED ANTI-alpha5ß1 INTEGRIN FUNCTION BLOCKING ANTIBODIES WITH REDUCED IMMUNOGENICITY |
| 03/11/2009 | EP2032604A2 Anti-dll4 antibodies and methods using same |
| 03/11/2009 | EP2032603A2 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
| 03/11/2009 | EP2032602A2 Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds |
| 03/11/2009 | EP2032167A2 A novel target in the treatment of cytokine release syndrome |
| 03/11/2009 | EP2032166A2 Compositions and methods for diagnosing and treating cancer |
| 03/11/2009 | EP2032164A1 Method for the preparation of specific antibodies against saccharidic antigens |
| 03/11/2009 | EP2032159A2 Combination of fcgammariib antibodies and cd20-specific antibodies and methods of use thereof |
| 03/11/2009 | EP1931216B1 Immunoglobulin and fatty acids |
| 03/11/2009 | EP1737488B1 Treatment of fungal infections |
| 03/11/2009 | EP1699826B1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 03/11/2009 | EP1691824B1 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 03/11/2009 | EP1601698B1 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 03/11/2009 | EP1506406B1 Diagnosis of hepatocellular carcinoma |
| 03/11/2009 | EP1429845B1 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 03/11/2009 | EP1355948B1 Materials and methods for treatment of hepatitis c |
| 03/11/2009 | EP1320756B1 Novel antibody, immunoassay and method for prostate cancer detection |
| 03/11/2009 | EP1268799B1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 03/11/2009 | EP1071763B1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 03/11/2009 | EP0837946B1 Detection of amplified nucleic acid sequences using bifunctional haptenization and dyed microparticles |
| 03/11/2009 | EP0741784B1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 03/11/2009 | CN101384901A Reagents and methods for cancer prognosis and pathological staging |
| 03/11/2009 | CN101384280A Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 03/11/2009 | CN101381410A Rhodamine 123 artificial antigen synthesis, antibody preparation method and application |
| 03/11/2009 | CN100467611C Purification of polypeptides |
| 03/11/2009 | CN100467603C DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme |
| 03/11/2009 | CN100467600C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/11/2009 | CN100467598C Fungal cell wall synthesis gene |
| 03/11/2009 | CN100467597C Fungal cell wall synthesis gene |
| 03/11/2009 | CN100467489C Specific antibodies proBNP(1-108) for diagnosing heart failure |
| 03/11/2009 | CN100467488C Il-7 fusion proteins |
| 03/11/2009 | CN100467487C Multifunctional polypeptide |
| 03/11/2009 | CN100467485C SARS coronary virus related polypeptide and its uses |
| 03/11/2009 | CN100467484C SARS early diagnostic method and reagent box |
| 03/10/2009 | US7501506 Pentopyranosyl nucleic acid does not non-covalently bond or hybridize to naturally occurring DNA or RNA; conjugated through a covalent linkage to the biotin molecule; diagnosis, gene therapy |
| 03/10/2009 | US7501498 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering |
| 03/10/2009 | US7501497 Comprising transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor moiety and an immunoglobulin moiety comprising a heavy chain constant region of an immunoglobulin; interfere with binding of a tumor necrosis factor receptor with its ligand; antitumor agents |
| 03/10/2009 | US7501496 Antibody binds OX40L, contains a Fc part derived from human origin; light chain and heavy chain variable domains defined by amino acid sequences and does not bind complement factor C1q; antiinflammatory, antiarthritic, antihistamine and bronchodilator agents; asthma treatment; gene expression |
| 03/10/2009 | US7501495 Method for improving recovery yield in protein purification with gel filtration chromatography |
| 03/10/2009 | US7501494 Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 03/10/2009 | US7501398 Peptide; HIV-1 PR inhibitors which effectively interferes with the folding mechanism of the protein itself, thus destabilizing it and making it prone to proteolysis; acquired immune deficiency syndrome |
| 03/10/2009 | US7501264 Monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 03/10/2009 | US7501263 Nucleic acids encoding mammalian T-type calcium channels |
| 03/10/2009 | US7501124 Administering allogenic or xenogeneric cell; complexing with antigen |
| 03/10/2009 | US7501123 Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 03/10/2009 | US7501122 Treating ErbB2-expressing breast cancer in a human by administering huMAb4D5-8 antibody and humanized 2C4 antibody variant 574 |
| 03/10/2009 | US7501121 IL-13 binding agents |
| 03/10/2009 | US7501119 Methods and molecules for modulating an immune response |
| 03/10/2009 | US7501118 Human gene relating to respiratory diseases and obesity |
| 03/10/2009 | US7501117 Proteolytic blood coagulation factor for treatment and prevention of preclampsia and thrombotic disorders |
| 03/10/2009 | CA2616144A1 Insect olfactory receptors and ligands therefor |
| 03/10/2009 | CA2270408C Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use |
| 03/10/2009 | CA2252896C Inactivation resistant factor viii |
| 03/10/2009 | CA2145278C Target binding polypeptide |
| 03/07/2009 | CA2639335A1 Anti-chikungunya monoclonal antibodies and uses thereof |
| 03/07/2009 | CA2598966A1 Anti-chikungunya monoclonal antibodies and uses thereof |
| 03/05/2009 | WO2009029831A1 Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
| 03/05/2009 | WO2009029669A1 Method of inhibiting complement activation with factor bb specific antibodies |
| 03/05/2009 | WO2009029591A2 Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods |
| 03/05/2009 | WO2009029550A2 Highly sensitive system and methods for analysis of prostate specific antigen (psa) |
| 03/05/2009 | WO2009029235A2 Peptides and proteins for early liver development and anitibodies thereto, and their use in therapeutic diagnosis and treatment |
| 03/05/2009 | WO2009029132A2 Antigen-binding proteins targeting s. aureus orf0657n |
| 03/05/2009 | WO2009029123A1 Antibodies to erythropoietin receptor and uses thereof |
| 03/05/2009 | WO2009028968A1 Cell marker of melanocyte cell lineage and uses thereof |
| 03/05/2009 | WO2009028663A1 Anti-claudin-3 antibody |
| 03/05/2009 | WO2009028662A1 Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin |
| 03/05/2009 | WO2009028639A1 Anti-epha2 antibody |
| 03/05/2009 | WO2009028575A1 Activator for blood coagulation factor vii promoter and utilization of the same |
| 03/05/2009 | WO2009028417A1 Detection method of gynecologic cancer |
| 03/05/2009 | WO2009027752A2 Process for producing hepcidin |
| 03/05/2009 | WO2009027471A1 Methods for increasing protein titers |
| 03/05/2009 | WO2009027470A1 LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS |
| 03/05/2009 | WO2009027391A1 Needle-free delivery device for therapeutic proteins based on single antigen-binding domains such as nanobodies® |